Loading provider…
Loading provider…
Orthopaedic Surgery Physician in Portland, OR
NPI: 1326056870Primary Practice Location
OHSU HOSPITAL AND CLINICS
700 Sw Campus Dr, Portland, OR
Primary Employer
University Professional Services
ohsu.edu
HQ Phone
Get MD James's Phone Numberphone_androidMobile
Get MD James's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOR State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 93 | 117 |
| 2 | 99203New patient outpatient visit, total time 30-44 minutes | 15 | 15 |
| 3 | 99204New patient office or other outpatient visit, 45-59 minutes | 13 | 13 |
Authors: Melissa Zimel, Benjamin Miller, Edward Cheng, Adrianna Carrasco
Journal: JAMA Oncol
Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma.
Authors: Matthew Svalina
Publication Date: 2016-12-07
Authors: Arthur Hung, Kelly Perlewitz, Brooke Beckett, Eve Rodler, Rodney Pommier, Janelle Meyer
Journal: Clin Cancer Res
Publication Date: 2013-10-16
Lead Sponsor: McMaster University
Collaborators: Canadian Institutes of Health Research (CIHR), Canadian Cancer Society (CCS), Musculoskeletal Tumor Society, Hamilton Academic Health Sciences Organization, American Academy of Orthopaedic Surgeons
Intervention / Treatment: OTHER: Frequency: Every 3 Months, OTHER: Frequency: Every 6 Months, OTHER: Imaging Modality: Chest Radiograph (CXR), OTHER: Imaging Modality: Chest CT
Lead Sponsor: Presage Biosciences
Collaborators: Oregon Health and Science University, University of Washington, Northwell Health, Fred Hutchinson Cancer Center
Intervention / Treatment: DRUG: Multiple drug microinjection, DEVICE: CIVO device
Lead Sponsor: McMaster University
Collaborators: Orthopedic Research and Education Foundation, Canadian Institutes of Health Research (CIHR), Canadian Cancer Society (CCS), The Physicians' Services Incorporated Foundation
Intervention / Treatment: DRUG: 24-Hour Prophylactic Cefazolin* Antibiotic Regimen, DRUG: 5-Days Prophylactic Cefazolin* Antibiotic Regimen